Literature DB >> 15547832

Renal function and outcome following salvage surgery for bilateral Wilms' tumor.

Rainer Kubiak1, Mohan Gundeti, Patrick G Duffy, Philip G Ransley, Duncan T Wilcox.   

Abstract

PURPOSE: Maintaining adequate renal function without compromising cure in children with bilateral Wilms' tumor is surgically demanding and challenging. The aim of this study was to assess renal function and outcome in children treated in one institution for bilateral Wilms' disease by renal salvage procedures.
METHODS: This study is a retrospective review of all patients with histologically proven bilateral nephroblastoma who underwent a renal salvage procedure between November 1973 and June 2002. The median follow-up time was 52 months (range, 8 to 326 months).
RESULTS: Twenty-three patients were included in the study. The median age at diagnosis was 19 months (range, 5 to 65 months). Patients who presented before 1982 (n = 5) were treated surgically first followed by chemotherapy. The remainder (n = 18) received initial chemotherapy before the operation. Of the 46 kidneys, 18 had a nephrectomy. The remaining 28 underwent a renal salvage procedure. At follow-up, 19 patients had good renal function, 2 had satisfactory function, and 2 had renal failure. Seventeen of the 23 children are alive and tumor free at follow-up (74%). Four children died of distant metastases and 2 of renal failure. Local recurrence in the salvaged kidney was detected in 1 patient 12 years after surgery after the commencement of immunosuppression for renal transplantation.
CONCLUSIONS: These results confirm that renal salvage procedures, in combination with chemotherapy, are a safe and effective way of treating children with bilateral Wilms' disease. In addition, renal salvage surgery can maintain satisfactory renal function in the majority of these patients without an increased risk of local recurrence. When transplantation is required, the remaining native kidney should be removed to prevent tumor recurrence.

Entities:  

Mesh:

Year:  2004        PMID: 15547832     DOI: 10.1016/j.jpedsurg.2004.07.009

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  7 in total

1.  Management of Bilateral Wilms' Tumor: Our Experience.

Authors:  Vinay Jadhav; Gowri Shankar
Journal:  Indian J Surg Oncol       Date:  2016-09-01

2.  Early postoperative complications in pediatric abdominal solid tumor surgery according to Clavian-Dindo classification.

Authors:  İdil Rana User; Burak Ardıçlı; Arbay Özden Çiftçi; İbrahim Karnak; Feridun Cahit Tanyel; Berna Oğuz; Mithat Haliloğlu; Tezer Kutluk; Ali Varan; Saniye Ekinci
Journal:  Pediatr Surg Int       Date:  2022-07-12       Impact factor: 2.003

3.  Management of Wilms' tumor: NWTS vs SIOP.

Authors:  Sushmita Bhatnagar
Journal:  J Indian Assoc Pediatr Surg       Date:  2009-01

4.  Overall Survival and Renal Function of Patients With Synchronous Bilateral Wilms Tumor Undergoing Surgery at a Single Institution.

Authors:  Andrew M Davidoff; Rodrigo B Interiano; Lynn Wynn; Noel Delos Santos; Jeffrey S Dome; Daniel M Green; Rachel C Brennan; M Beth McCarville; Matthew J Krasin; Kathleen Kieran; Mark A Williams
Journal:  Ann Surg       Date:  2015-10       Impact factor: 12.969

5.  Nephron sparing surgery for unilateral non-syndromic wilms tumor.

Authors:  R B Nerli; V C Pujar; M B Hiremath; S M Jali; S S Joshi; S C Hiremath; A K Guntaka
Journal:  Indian J Surg Oncol       Date:  2014-01-22

6.  Early and late adverse renal effects after potentially nephrotoxic treatment for childhood cancer.

Authors:  Esmee Cm Kooijmans; Arend Bökenkamp; Nic S Tjahjadi; Jesse M Tettero; Eline van Dulmen-den Broeder; Helena Jh van der Pal; Margreet A Veening
Journal:  Cochrane Database Syst Rev       Date:  2019-03-11

7.  Bilateral Renal Tumors in Children: The First 5 Years' Experience of National Centralization in The Netherlands and a Narrative Review of the Literature.

Authors:  Sophie E van Peer; Janna A Hol; Alida F W van der Steeg; Martine van Grotel; Godelieve A M Tytgat; Annelies M C Mavinkurve-Groothuis; Geert O R Janssens; Annemieke S Littooij; Ronald R de Krijger; Marjolijn C J Jongmans; Marc R Lilien; Jarno Drost; Roland P Kuiper; Harm van Tinteren; Marc H W A Wijnen; Marry M van den Heuvel-Eibrink
Journal:  J Clin Med       Date:  2021-11-26       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.